On the hyperglycaemic effect of DOPA and dopamine.
D000496:Alloxan / Q000494:pharmacology; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000494:pharmacology*; D006943:Hyperglycemia / Q000139:chemically induced / Q000188:drug therapy*; D007275:Injections, Intravenous; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D008996:Monoamine Oxidase Inhibitors; D004295:Dihydroxyphenylalanine; D000496:Alloxan; D014044:Tolbutamide; D004298:Dopamine